Paludo, Jonas
Abeykoon, Jithma P.
Shreders, Amanda
Ansell, Stephen M.
Kumar, Shaji
Ailawadhi, Sikander
King, Rebecca L.
Koehler, Amber B.
Reeder, Craig B.
Buadi, Francis K.
Dispenzieri, Angela
Lacy, Martha Q.
Dingli, David
Witzig, Thomas E.
Go, Ronald S.
Gonsalves, Wilson I.
Kourelis, Taxiarchis
Warsame, Rahma
Leung, Nelson
Habermann, Thomas M.
Hayman, Suzanne
Lin, Yi
Kyle, Robert A.
Rajkumar, S. Vincent
Gertz, Morie A.
Kapoor, Prashant
Article History
Received: 21 September 2017
Accepted: 19 March 2018
First Online: 3 April 2018
Compliance with ethical standards
: The study was approved by the institutional review board and conducted in accordance with the Declaration of Helsinki.
: Informed consent prior to the data collection and analysis for research purposes was obtained from the subjects in the study.
: Dr. Ansell has received research funding from Bristol-Myers Squibb, Celldex, Merck, Affimed, and Seattle Genetics. Dr. Kumar has received honoraria from Skyline Diagnostics. Research support from Abbvie, Celgene, Novartis, Amgen, Takeda, Sanofi, and Janssen has been provided to Institution for conduct of clinical trials on which Dr. Kumar serves as a principal investigator. Dr. Ailawadhi has served as a consultant for Novartis Pharmaceuticals, Amgen Pharmaceuticals, Pharmacyclics, Inc., and Takeda and has received research funding from Pharmacyclics, Inc. Dr. Reeder has received research support from Celgene, Novartis, and Millennium. No other disclosures are reported. Dr. Dispenzieri has received research support from Celgene, Takeda, Pfizer, Alnylam, Prothena, and Jannsen. Dr. Lacy receives research funding from Celgene. Dr. Dingli has received research funding from Takeda, Karyopharm, and Amgen. Dr. Witzig reports receiving research funding from Celgene (Institution), Novartis (Institution), Spectrum Pharmaceuticals (Institution), and Acerta Pharma (Institution). Dr. Lin receives research funding from Janssen. Dr. Gertz has received research support from Ionis Pharmaceuticals and Prothena and honoraria from Celgene, Millennium Pharmaceuticals, and Novartis. Dr. Kapoor has received research funding from Takeda (Institution), Onyx (Institution), and Celgene (Institution) and consulting fees from Celgene and Sanofi (Institution). The rest of the authors declare that they have no conflict of interest.